Skip to main content
Caplight Logo









Australian Natural Therapeutics Group

Australian Natural Therapeutics Group

Private
Byron BayHealthcare & Life Scienceshttps://antg.com.au/

Last Round

Grant

Dec 10, 2025

Total Funding Raised

$1.34M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Australian Natural Therapeutics Group is a pharmaceutical and biotechnology company that specializes in the cultivation, manufacturing, and research of medicinal cannabis products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Pharma Supply Chain, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

medicinal cannabismedical marijuanapharmaceutical-grade cannabiscannabinoid extractsgood agricultural and collection practicesGACPgood manufacturing practiceGMPcannabis cultivationmedicinal cannabis flowercannabis oilproprietary cannabis cultivarsmedical cannabis supplybiotechclinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Australian Natural Therapeutics Group Comparables

Compare Australian Natural Therapeutics Group with similar companies based on industry and business-model similarity.

Australian Natural Therapeutics Group comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tasmanian Botanics
89%
Cymra Life Sciences
88%
Medcan Australia
87%

Australian Natural Therapeutics Group Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 10, 2025
GrantAug 4, 2022

Australian Natural Therapeutics Group Investors

Notable investors and investment history

Australian Natural Therapeutics Group investors
InvestorRounds
NSW GovernmentGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 11, 2026

    Monthly visitors increased 469% MoM, reaching 2.5K.

  • Mar 1, 2026

    Monthly visitors increased 31% MoM.

Australian Natural Therapeutics Group Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Australian Natural Therapeutics Group Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Australian Natural Therapeutics Group's valuation, stock price, and market status.

Firmographic Details

HeadquartersByron Bay
Employee Range46
Year Founded2016
Last FundingDec 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?